TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer is skeptical Dow Chemical's (DOW) proposed merger with DuPont (DD) will be approved by regulators. 'I have been saying that the EU may not even let this deal go through,' Cramer said. 'Both sides remain confident that it's going to go through, but I question that.' On Friday, the EU Commission put its investigation of the deal on hold.
More from Video
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Breaking down an approach to the long side of this biotech stock.
AMSC CEO discusses that and China challenges.
One of pharma's biggest CEO's talks M&A action on the exchange.